Prescription drug abuse among club drug users

  • Description
  • Details
  • Subprojects
  • History
  • Relations
  • Publications
Project Title: Prescription drug abuse among club drug users
Principal Investigators (PI): INCIARDI JAMES A
Project Number: 5R01DA019048-04
Organization: UNIVERSITY OF DELAWARE
 
Project Description:
The non-medical use of Pharmaceuticals has been a long-standing problem in the United States, and since the 1970s the use of "club drugs" has been a problem among adolescents and young adults. A recent trend has been the incursion of prescription drugs into the club culture, with the concomitant health consequences associated with their abuse. Because of their young age and their tendency to mix numerous drugs during any given drug binge, club drug users tend to be a highly vulnerable population. Within this context, the specific aims of this application are to; 1) recruit a sample of 750 out-of-treatment prescription and club drugs abusers ages 18-39 and at baseline assess their life histories of alcohol and drug abuse onset and progression, and extent of current alcohol and prescription, club and other drug use; 2) at 6, 12 and 18 months, assess changes in onset, progression, and extent of respondents' alcohol and prescription, club and other drug use; 3) at baseline, 6, 12 months and 18 months, assess the mechanisms of access to prescription drugs among the sampled drug users; 4) at baseline, 6, 12 and 18 months, investigate the impact of quantity, frequency, types and duration of prescription and club drug abuse on the nature and extent of health and social consequences within this population, including: sexual risk-taking and coercion; drug interactions and overdose; chronic drug use; impairment of daily activities; physical problems; mental health problems; and legal problems; and 5) examine the impact of gender and other potential correlates (sexual identity, sexual history, current sexual behaviors, drug history, and current drug use) on onset, progression, and extent of prescription, club and other drug abuse and the nature and extent of health and social consequences. The study sample will reflect the race/ethnic distribution of the Miami population: 30 percent white/Anglo, 50 percent Hispanic, and 20 percent African-American, with a gender distribution of 50 percent female and 50 percent male. A variety of statistical techniques will be used to describe the population, the epidemiology of prescription and other drug use in the club culture, and the nature and prevalence of related consequences. The short-term objectives are to describe the changing nature of prescription drug abuse/club drug use and their consequences in the Miami club culture. A broader long-term goal is to better understand current patterns of the abuse of prescription drugs and their incursion into the club culture, in order that strategies can be developed for reducing the abuse and diversion of these drugs in Miami and other communities. Such strategies and policies may ultimately reduce the abuse and diversion of prescription drugs, as well as make them more readily available to the patients for whom they are intended.
 
Project Terms:
1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl- 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)- 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone 2-Methyl-3-(2-methylphenyl)-4(3H)-quinazolinone 2-Methyl-3-o-tolyl-4(3H)-quinazolinone 2-Piperidineacetic acid, alpha-phenyl-, methyl ester 3,4 methylenedioxymethamphetamine 3,4-Dihydro-2-methyl-4-oxo-3-o-tolylquinazoline 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl- 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Abbott brand of sildenafil citrate Addiction, Drug Adolescent Adolescent Youth Advocate African American Afro American Afroamerican Age Alcohols Alprazolam Alprazolan American Americas Amphetamines Analysis, Data Anesthestic Drugs Anesthetic Agents Anesthetic Drugs Anesthetics Apo-Alpzar Area Arts Barbiturates Benzeneethanamine, N,alpha-dimethyl-, (S)- Benzeneethanamine, alpha-methyl-, (S)- Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (S-(R*,S*))- Black Populations Black or African American British Chemical Class, Alcohol Chemical Dependence Chronic Clinical Medicine Cocaine Coercion Communities Crystal Meth D-Propoxyphene Daily Dancing Dancings Darvon Data Data Analyses Delaware Demerol Dental Calculus Deoxyephedrine Dependence, Drug Desoxyephedrine Destinations Dexamfetamine Dexedrine Dextroamphetamine Dextropropoxyphene Diazepam Dihydrocodeinone Dihydrohydroxycodeinone Dihydromorphinone Dilaudid Dilaudid HP Dimorphone Disease Disorder Dormutil Drug Addiction Drug Combinations Drug Dependency Drug Interactions Drug Prescribing Drug Prescriptions Drug abuse Drug abuser Drug usage Drug user Drugs Drugs, Non-Prescription Drugs, Nonprescription Du Pont Brand of Hydrocodone Tartrate Ecstasy Ecstasy - drug England Epidemiology Ethnic Origin Ethnicity Ethnicity aspects FDA Fathers Female Florida Focus Groups Food and Drug Administration Food and Drug Administration (U.S.) Frequencies (time pattern) Frequency Future Gender General Population General Public Generalized Growth Goals Growth HIV Infections HTLV-III Infections HTLV-III-LAV Infections Hand Health Health Services Hispanic Populations Hispanics Hispanics or Latinos History Household Hycodan Hycodan brand of hydrocodone bitartrate Hycon Hydrocodone Hydromorphon Hydromorphone Hydrostat Hymorphan Impairment Institutes International Internet Intervention Intervention Strategies Investigation Investigators Ipecac Isonipecain Ketamine Latin America Latino Population Laudacon Laudicon Legal Licorice Liquorice Literature Lorcet MAOA MDMA MTQ Medical Medical Sciences, Clinical Medication Mental Health Mental Hygiene Mentors Meperidine Methamphetamine Methaqualone Methods and Techniques Methods, Other Methylamphetamine Methylenedioxymethamphetamine Methylphenidate Metolquizolone Misuses drugs Monitor Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)- Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, (5alpha)- Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)- N-Methyl-3,4-methylenedioxyamphetamine N-Methylamphetamine NIDA National Institute of Drug Abuse Nature New York Non-Prescription Drugs Novolauden Nu-Alpraz Nu-Pharm Brand of Alprazolam NuAlpraz Numbers OTC Drugs Opioid Opium Ortonal Over-the-Counter Drugs Overdose Oxycodeinon Oxycodone Oxycodone SR Oxycontin Participant Patent Medicines Patients Pattern Pentazocine Percocet Pethidine Pfizer brand of sildenafil citrate Pharmaceutic Preparations Pharmaceutical Agent Pharmaceutical Preparations Pharmaceuticals Pharmacia Brand of Alprazolam Pharmacologic Substance Pharmacological Substance Physical activity Physicians Policies Population Powder dose form Powders Preparation Prescription Prescriptions, Drug Prevalence Prevention Prevention program Principal Investigator Problem drug user Process Programs (PT) Programs [Publication Type] Promoter Promoters (Genetics) Promotor Promotor (Genetics) Property Property, LOINC Axis 2 Propoxyphene Proxyphen Psychological Health Publishing Quaalude Race Racial Group Recording of previous events Recruitment Activity Research Research Personnel Researchers Respondent Risk Risk-Taking Rohypnol Roxicodone Rural Sales Sampling Sampling Studies Sex Behavior Sexual Activity Sexual Behavior Somnafac Spanish Origin Stealing Stealings Stocks, Racial Students Study Section Survey Instrument Surveys T-Lymphotropic Virus Type III Infections, Human Tafil Target Populations Tartar Techniques Theft Time Tissue Growth Trankimazin USFDA United States United States Food and Drug Administration Universities Upjohn Brand of Alprazolam Valium Viagra Vicodin Vulnerable Populations WWW Western Europe Wine Work Xanax abuse of drugs abuses drugs adult youth barbiturate barbituric acid salt black American club drug club drug abuse college coral d-Amphetamine dextro-Amphetamine disease/disorder drug use drug/agent ecstasy experience experiment experimental research experimental study health care service hispanic community innovate innovation innovative interventional strategy juvenile juvenile human life history male member nitric acid potassium salt ontogeny percodan population survey potassium nitrate preference prescription document prescription drug abuse prescription procedure programs recruit research study restoration saltpetre sedative sex sex activity social trend web world wide web young adult
Project Title: Prescription drug abuse among club drug users
Principal Investigators (PI): INCIARDI JAMES A
Project Number: 5R01DA019048-04
Organization: UNIVERSITY OF DELAWARE
 
Project Categories:
Events and Training Programs > Meetings
 
Other Information:
Fiscal Year: 2005
Project Start Date: 1 August 2005
Project End Date: 31 July 2010
Administering Institute Or Center: DA
 
Project Funding Information:
Total Funding: $575,361
Year Funding Organization Total Funding, $
2008 NATIONAL INSTITUTE ON DRUG ABUSE $575,361
Project Title: Prescription drug abuse among club drug users
Principal Investigators (PI): INCIARDI JAMES A
Project Number: 5R01DA019048-04
Organization: UNIVERSITY OF DELAWARE
 
Project_number Title Year FY Total Cost
There are no results for this project in database.
Project Title: Prescription drug abuse among club drug users
Principal Investigators (PI): INCIARDI JAMES A
Project Number: 5R01DA019048-04
Organization: UNIVERSITY OF DELAWARE
 
Project number Project title Organization FY Funding Organization FY Total Cost
5U01DA016230-03Delaware and New Jersey CJ-DATS Research CenterUNIVERSITY OF DELAWARE2004NATIONAL INSTITUTE ON DRUG ABUSE
$711,770
3U01DA016230-03S1Delaware and New Jersey CJ-DATS Research CenterUNIVERSITY OF DELAWARE2004NATIONAL INSTITUTE ON DRUG ABUSE
$97,500
5R01DA013131-05BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2004NATIONAL INSTITUTE ON DRUG ABUSE
$506,410
5U01DA016230-02Delaware and New Jersey CJ-DATS Research CenterUNIVERSITY OF DELAWARE2003NATIONAL INSTITUTE ON DRUG ABUSE
$712,217
5R37DA006124-15ONGOING STUDIES OF TREATMENT FOR HIGH RISK DRUG USERSUNIVERSITY OF DELAWARE2003NATIONAL INSTITUTE ON DRUG ABUSE
$1,193,627
5R01DA013131-04BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2003NATIONAL INSTITUTE ON DRUG ABUSE
$564,423
1U01DA016230-01Delaware and New Jersey CJ-DATS Research CenterUNIVERSITY OF DELAWARE2002NATIONAL INSTITUTE ON DRUG ABUSE
$540,813
5R37DA006124-14ONGOING STUDIES OF TREATMENT FOR HIGH RISK DRUG USERSUNIVERSITY OF DELAWARE2002NATIONAL INSTITUTE ON DRUG ABUSE
$1,158,857
5R01DA013131-03BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2002NATIONAL INSTITUTE ON DRUG ABUSE
$505,234
3R01DA013131-03S1BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2002NATIONAL INSTITUTE ON DRUG ABUSE
$82,226
5R37DA006124-13ONGOING STUDIES OF TREATMENT FOR HIGH RISK DRUG USERSUNIVERSITY OF DELAWARE2001NATIONAL INSTITUTE ON DRUG ABUSE
$1,125,104
5R01DA013131-02BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2001NATIONAL INSTITUTE ON DRUG ABUSE
$512,005
3R01DA013131-02S1BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2001NATIONAL INSTITUTE ON DRUG ABUSE
$75,000
5R37DA006124-12ONGOING STUDIES OF TREATMENT FOR HIGH RISK DRUG USERSUNIVERSITY OF DELAWARE2000NATIONAL INSTITUTE ON DRUG ABUSE
$1,092,329
4R37DA006124-11ONGOING STUDIES OF TREATMENT FOR HIGH RISK DRUG USERSUNIVERSITY OF DELAWARE2000NATIONAL INSTITUTE ON DRUG ABUSE
$765,925
1R01DA013131-01A1BRIEF HIV INTERVENTIONS FOR DRUG-USING WOMEN SEX WORKERSUNIVERSITY OF DELAWARE2000NATIONAL INSTITUTE ON DRUG ABUSE
$640,347
1R01DA019048-01A1Prescription Drug Abuse Among Club Drug UsersUNIVERSITY OF DELAWARE2005NATIONAL INSTITUTE ON DRUG ABUSE
$630,305
5U01DA016230-04Delaware and New Jersey CJ-DATS Research CenterUNIVERSITY OF DELAWARE2005NATIONAL INSTITUTE ON DRUG ABUSE
$815,179
2R01DA013131-06A2Case Management Alternatives for African American Women at High Risk for HIVUNIVERSITY OF DELAWARE2006NATIONAL INSTITUTE ON DRUG ABUSE
$607,839
5R01DA019048-02Prescription Drug Abuse Among Club Drug UsersUNIVERSITY OF DELAWARE2006NATIONAL INSTITUTE ON DRUG ABUSE
$587,622
Project Title: Prescription drug abuse among club drug users
Principal Investigators (PI): INCIARDI JAMES A
Project Number: 5R01DA019048-04
Organization: UNIVERSITY OF DELAWARE
 
Project number Project title Principal investigator
There are no any related projects.
Project Title: Prescription drug abuse among club drug users
Principal Investigators (PI): INCIARDI JAMES A
Project Number: 5R01DA019048-04
Organization: UNIVERSITY OF DELAWARE
 
Title Abstract Authors Year Rel